Live and Thrive: Feeling Your Best With MS
…
Multiple sclerosis drug mitoxantrone may be linked to increased risk of colorectal cancer
…
Stuart Schlossman
MS Meds: Do I Really Need Them?
…
Stuart Schlossman
Severe Rebound Effects Found in ‘Relevant’ Number of MS Patients After Stopping Fingolimod
…
Stuart Schlossman
Zinbryta (daclizumab HYP) is favored for approval in Europe
…
Stuart Schlossman
Biogen, AbbVie multiple sclerosis drug wins EU green light
…
Stuart Schlossman
Sanofi Genzyme Presenting New Data on Lemtrada’s Beneficial Effects, Drawn from RRMS Extension Study, at AAN 2016
…
Stuart Schlossman
Biogen Releases New Data Showing Effectiveness of Tecfidera in Newly Diagnosed MS Patients at AAN 2016
…
Stuart Schlossman
Biogen and AbbVie Present New Data Showing Zinbryta, an RRMS Drug Candidate, Aids Cognition Without Immune Depletion
…
Stuart Schlossman
Edward Fox from the MS Clinic of Central Texas: Alemtuzumab’s Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment –
…
Stuart Schlossman
